Artelo Biosciences (ARTL) Return on Capital Employed Growth (1y) (2016 - 2025)
Artelo Biosciences (ARTL) Return on Capital Employed Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -785.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,629.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3,193.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -28.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 399.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -310.00 |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | 247,994.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 247,994.00 |
| Sep 30, 2025 | 240,382.00 |
| Jun 30, 2025 | 72,366.00 |
| Mar 31, 2025 | -66,676.00 |
| Dec 31, 2024 | -16,736.00 |
| Sep 30, 2024 | -6,898.00 |
| Jun 30, 2024 | -7,217.00 |
| Mar 31, 2024 | -3,608.00 |
| Dec 31, 2023 | -2,613.00 |
| Sep 30, 2023 | -2,576.00 |
| Jun 30, 2023 | -1,529.00 |
| Mar 31, 2023 | -1,805.00 |
| Nov 30, 2021 | 2,686.00 |
| May 31, 2021 | 7,757.00 |
| Feb 28, 2021 | 5,285.00 |
| Nov 30, 2020 | -526.00 |
| May 31, 2020 | -160,208.00 |
| Feb 29, 2020 | -40,772.00 |
| Nov 30, 2019 | -80,348.00 |
| Aug 31, 2019 | -187,704.00 |